SEC 13F Intelligence

Boxer Capital, LLC / SNDX

Boxer Capital, LLC’s Syndax Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Syndax Pharmaceuticals Inc (SNDX)? Not currently — the last reported position was 2.29M shares worth $44M in Q3 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$44M
Q3 2021
Shares
2.29M
% of Portfolio
+1.53%
Quarters Held
9
position exited

Position History SNDX

Reported value by quarter
Q3 ’19: $3MQ3 ’19Q4 ’19: $2MQ1 ’20: $8MQ1 ’20Q2 ’20: $34MQ3 ’20: $34MQ3 ’20Q4 ’20: $51MQ1 ’21: $51MQ1 ’21Q2 ’21: $39MQ3 ’21: $44MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20212.29M$44M+1.53%
Q2 20212.29M$39M+1.39%
Q1 20212.29M$51M+1.73%
Q4 20202.29M$51M+1.64%
Q3 20202.29M$34M+1.17%
Q2 20202.29M$34M+1.49%
Q1 2020725.8K$8M+0.54%
Q4 2019250.0K$2M+0.12%
Q3 2019400.0K$3M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of SNDX.